Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 30;13(1):e12999.
doi: 10.7759/cureus.12999.

Keloid Scars: An Updated Review of Combination Therapies

Affiliations
Review

Keloid Scars: An Updated Review of Combination Therapies

Nicholas J Thornton et al. Cureus. .

Abstract

Keloid scars are a common yet poorly understood complication of wound healing that can cause a diminished quality of life. Currently, there is little agreement amongst the medical community regarding the best treatment modality for keloids. For this reason, we have created an updated review of the most successful combination therapies for keloid scars and compared their efficacy based on rates of recurrence following treatment. Additionally, these combination therapies have been compared with intralesional triamcinolone acetonide corticosteroid (TAC), which is considered the mainstay monotherapy for keloids. All combination therapies included in our review were shown to produce superior outcomes than TAC monotherapy. We have also found that certain combination therapies are known to produce superior results when used in specific anatomic locations. Intralesional TAC plus intralesional cryotherapy appeared to have the most promising results for non-auricular keloids, and the authors suggest considering this as a first-line treatment. Additionally, the use of surgical excision plus compression therapy achieved superior results for auricular keloids and should be considered first-line for keloids in these locations.

Keywords: combination therapy for keloid scars; combination therapy for keloids; combination treatment for keloids; combination versus monotherapy for keloids; keloid; keloid scar; keloid therapy; keloid treatment; treating keloids.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. The keloid disorder: heterogeneity, histopathology, mechanisms and models. Limandjaja GC, Niessen FB, Scheper RJ, Gibbs S. https://link.gale.com/apps/doc/A624926054/HRCA Front Cell Dev Biol. 2020 - PMC - PubMed
    1. Keloids: a review of therapeutic management. Ekstein SF, Wyles SP, Moran SL, Meves A. Int J Dermatol. 2020 - PMC - PubMed
    1. A review of current keloid management: mainstay monotherapies and emerging approaches. Limmer EE, Glass DA. Dermatol Ther. 2020;10:931–948. - PMC - PubMed
    1. Optimizing radiotherapy for keloids: a meta-analysis systematic review comparing recurrence rates between different radiation modalities. Mankowski P, Kanevsky J, Tomlinson J, et al. Ann Plastic Surge. 2017;78:403–411. - PubMed
    1. Triamcinolone acetonide intralesional injection for the treatment of keloid scars: patient selection and perspectives. Morelli Coppola M, Salzillo R, Segreto F, et al. Clin Cosmetic Investigational Dermatol. 2018;11:387–396. - PMC - PubMed

LinkOut - more resources